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MRI screening to characterize tumors in dogs
Masses in spleens or livers of dogs are relained 20 dogs that had been scheduled for a
between MRI and ultrasound were not
tively common findings for the veterinarian.
splenectomy and/or liver biopsy.
possible.
They are often noted during the routine physiThe dogs were taken to a research MRI at
In two cases the MRI found pulmonary
cal exam or during ultrasound imaging of the
HUP. Technicians and clinicians from VHUP
metastasis not seen on radiographs. MRI also
abdomen. These lesions may be a result of
accompanied the animals to handle anesthesia
showed the exact location of the tumor, maktrauma, hyperplasia, and benign or malignant
and contrast medium infusion. The MRI
ing it easier for surgeons if removal was
tumors. Benign lesions in the liver are more
images were read by two radiologists (Drs. E.S.
required in several cases.
common than malignant ones, though cliniPretorius and E. Siegelman) from HUP who
“It appears that MRI imaging maybe a usecians cannot automatically assume that a mass
used guidelines established for liver and splenic
ful screening method for canine patients with
is benign. To determine the character of a
tumors in humans.
focal splenic or liver lesions,” says Dr. Craig
lesion, ultrasound and biopsies are used as
The animals then underwent a liver biopsy
Clifford, resident in oncology and primary
diagnostic tools.
investigator.
Ultrasound is
“We are
an excellent
enlarging the
modality for
study to look
determining the
at a bigger
presence of a
group. If the
mass but often
results hold
the ultrasonogtrue, then it is
rapher cannot
possible that
say whether it is
some biopsies
truly benign or
and surgeries
malignant. That
of benign
is determined
lesions can be
definitively only
prevented. The
by biopsy. In
MRI modality
human medialso shows a
cine, for a nummore exact
ber of years,
location of a
MRI imaging
mass, making
has been used to
it easier for the
T2 image
T1 Late Post-Gad
characterize
surgeon, in
lesions in the
A mass diagnosed as a cancer based upon abnormal appearance on the T2 image and called a hepatocellular carcinoma due to sim- several cases,
liver and spleen. ilarities to the rest of the liver on the T1 image. It was read as “low-grade” because it did not contrast enhance. This was proven MRI provided
MRI images have after surgical resection of the tumor.
the surgeon
advantages over
with valuable
ultrasound images in providing a much more
or splenectomy and the removed tissues were
information. One additional benefit of MRI
defined, soft tissue imaging modality. MRI is
then examined by the veterinary school’s
and its superior soft tissue imaging is that we
considered the “Gold Standard” of imaging for
pathologists. The MRI imaging characteristics
can use it to follow a tumor while it is treated
the liver and spleen in people. MRI in people
were correlated with the pathologic findings to
with chemotherapy; the MRI allows us to see
can not only determine whether a lesion is
determine whether the expected MRI imaging
whether the tumor is shrinking. This is particbenign or malignant, but can further define
characteristics of benign and maligant canine
ularly important when new drug regimens
whether it is a primary or metastatic (cancer
spleenic and liver lesions were the same as such
which are designed to kill the blood vessels
spread) lesion. To determine whether canine
lesions in humans.
supplying the tumor are tried, for example, for
benign and malignant tumors in the spleen
Using the MRI imaging characteristics for
hemangiosarcomas” (blood vessel tumor).
and liver can be diagnosed through MRI, clinihuman benign and malignant liver and spleen
The clinicians participating in the initial
cians at VHUP and at HUP, (the hospital for
lesions, radiologists at HUP identified 16 out of
pilot study are Drs. Clifford, Chick Weisse,
humans a few blocks away), designed a study
17 benign lesions and 15 out of 15 malignant
V’98, and Karin Sorenmo of VHUP, and E.S.
for MRI screening of dogs with focal splenic
lesions. The overall accuracy was 31/32 lesions
Pretorius, E. Siegelman and J.A. Solomon of
and liver lesions.
thus far. These findings were confirmed by the
HUP. This study was presented by Dr. Clifford
Dogs, unlike humans, have to be aneshistopathology exam of biopsied or removed
at the 22nd Annual Veterinary Cancer Society
thetized for an MRI as they are required to be
tissues. The animals were also examined by
Conference in New York this past September
perfectly still. Cases were selected from patients
ultrasound, however, in the majority of cases,
and received the Clinical Research Award.
presented at VHUP’s clinics. The study examno specific diagnosis was given, so comparisons
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